| 中文名 | 4-(氯甲基)-2-(4-氯苯基)-5-甲基噁唑 |
|---|---|
| 英文名 | 4-(Chloromethyl)-2-(4-chlorophenyl)-5-methyl-1,3-oxazole |
| 英文别名 |
4-(chloromethyl)-5-methyl-2-[4-chlorophenyl]oxazole
4-(chloromethyl)-2-(4-chlorophenyl)-5-methyloxazole |
| 分子式 | C11H9Cl2NO |
|---|---|
| 分子量 | 242.10100 |
| 精确质量 | 241.00600 |
| PSA | 26.03000 |
| LogP | 4.04220 |
|
~%
832076-92-3 |
| 文献:Malamas; Carlson; Grimes; Howell; Glaser; Gunawan; Nelson; Kanzelberger; Shah; Hartman Journal of Medicinal Chemistry, 1996 , vol. 39, # 1 p. 237 - 245 |
|
~63%
832076-92-3 |
| 文献:Yamane, Taihei; Mitsudera, Hiroyuki; Shundoh, Takatsugu Synthesis, 2004 , # 17 p. 2825 - 2832 |
|
~94%
832076-92-3 |
| 文献:Bristol-Myers Squibb Company Patent: US2008/9533 A1, 2008 ; Location in patent: Page/Page column 14-15 ; US 20080009533 A1 |
|
~%
832076-92-3 |
| 文献:Lee, George T.; Jiang, Xinglong; Vedananda; Prasad, Kapa; Repic, Oljan Advanced Synthesis and Catalysis, 2004 , vol. 346, # 12 p. 1461 - 1464 |
| 上游产品 5 | |
|---|---|
| 下游产品 0 | |